MorphoSys AG Receives Consensus Rating of Hold from Brokerages
Slightly above 67% of MorphoSys' investor base is looking to short. The analysis of current outlook of investing in MorphoSys AG ADR suggests that many traders are alarmed regarding MorphoSys' prospects. MorphoSys' investing sentiment overview a quick insight into current market opportunities from investing in MorphoSys AG ADR. Many technical investors use MorphoSys AG ADR stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
MorphoSys |
MorphoSys AG has been given a consensus rating of Hold by the eight research firms that are currently covering the firm, Marketbeat.com reports. Five analysts have rated the stock with a sell rating, one has issued a hold rating and two have issued a buy rating on the company. The average
Read at thelincolnianonline.com
 |
MorphoSys Fundamental Analysis
We analyze MorphoSys' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MorphoSys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MorphoSys based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
MorphoSys is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
MorphoSys AG ADR Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MorphoSys stock to make a market-neutral strategy. Peer analysis of MorphoSys could also be used in its relative valuation, which is a method of valuing MorphoSys by comparing valuation metrics with similar companies.
Peers
MorphoSys Related Equities
| NVCT | Nuvectis Pharma | 3.98 | ||||
| KRON | Kronos Bio | 1.06 | ||||
| IPSC | Century Therapeutics | 0.99 | ||||
| CGEM | Cullinan Oncology | 0.83 | ||||
| PCVX | Vaxcyte | 0.62 | ||||
| LYRA | Lyra Therapeutics | 0.53 | ||||
| RLYB | Rallybio Corp | 0.43 | ||||
| MLYS | Mineralys Therapeutics, | 0.00 | ||||
| EWTX | Edgewise Therapeutics | 0.00 | ||||
| PMVP | Pmv Pharmaceuticals | 0.00 | ||||
| REPL | Replimune | 0.00 | ||||
| MRSN | Mersana Therapeutics | 0.00 | ||||
| GBIO | Generation Bio | 0.00 | ||||
| ELVN | Enliven Therapeutics | 0.94 | ||||
| IMCR | Immunocore Holdings | 1.23 | ||||
| ACLX | Arcellx | 1.52 | ||||
| GLUE | Monte Rosa | 2.22 | ||||
| GOSS | Gossamer Bio | 2.36 | ||||
| CCCC | C4 Therapeutics | 2.64 | ||||
| IMRX | Immuneering Corp | 3.86 | ||||
| VTYX | Ventyx Biosciences | 6.30 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in MorphoSys Stock
If you are still planning to invest in MorphoSys AG ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MorphoSys' history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |